As the Indiana Pacers explore ways to bolster their roster for the 2026-27 NBA season, a new name has surfaced on their radar—and it belongs to a promising talent from the Boston Celtics.
In a recent Bleacher Report column, NBA analyst Dan Favale identified Celtics guard Jordan Walsh as a prime trade target for Indiana.
For the fast-paced, offensively charged Pacers, the appeal of acquiring Walsh is clear. At 22 years old with a 7-foot-2 wingspan, Walsh possesses the raw defensive versatility Indiana desperately needs to balance its roster.
“Jordan Walsh can defend all over the floor and only makes $2.4 million this season,” Favale noted in his column, highlighting the massive value the young defender provides on his current deal.
The “Poison Pill” and the Finances
When discussing potential trades for Walsh, the immediate technical obstacle is his contract status. The former Arkansas standout recently signed a three-year, $15 million extension with Boston.
However, Favale argues that the low financial figures attached to Walsh’s deal mitigate this challenge. “His extension was cheap enough at three years and $15 million that the poison pill provision isn't a huge hurdle,” Favale explained.
The Real Obstacle: Boston’s Rotation
While the financials might align for Indiana, the Boston Celtics stand as the primary roadblock. Walsh is no longer just a developmental prospect; he has grown into a valuable, cost-controlled rotation piece under head coach Joe Mazzulla.
“His importance to the Celtics is the bigger obstacle,” Favale pointed out.
Walsh’s defensive chops have earned him significant trust in Boston, even propelling him into the starting five during the preseason and the Celtics' regular-season opener against the Detroit Pistons.
Favale warned that Indiana will have a much harder time calling about Walsh if he stays inside Boston's opening five.
Related Article: NBA Free Agency Rumor: Lakers ex-wingman 3 potential destination?

Comments
Post a Comment